Guaifenesin D Tablet, Extended Release
Product Images NDC 0363-9930

1 FDA label image from Walgreen Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin D (NDC 0363-9930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Walgreen Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (36 Tablet Blister Pack Carton)

Principal Display Panel (36 Tablet Blister Pack Carton)
The packaging label for Walgreens Mucus Relief D extended-release tablets contains 600 mg guaifenesin and 60 mg pseudoephedrine hydrochloride. The oral tablet comes in a 36-count box and is designed for 12-hour relief. The label features Walgreens branding, tablet illustrations showing immediate and extended-release layers, and states it is an expectorant and nasal decongestant manufactured by Walgreen Company.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.